Skip to search formSkip to main contentSkip to account menu
Drug development: The treasure chest
Pharmaceutical research into the chemicals found in cannabis has so far supplied only one licensed medicine. But scientists think there could be hundreds more.
View on Nature
Long-term research: Slow science
View on Nature
Data sharing: Access all areas
TLDR
A neuroscience institute plans to put the theory that open science will be good for innovation to the test and see if it can be shown to work.
View on Nature
Golden Rice is safe to eat, says FDA
TLDR
Golden Rice, the staple food genetically designed to contain beta carotene, a precursor to vitamin A, has been judged safe to eat by the US Food and Drug Administration (FDA), and many, however, will see this latest move from the US agency as a stamp of approval.
View on Nature
Behind New Zealand’s wild plan to purge all pests
The country is gearing up to get rid of rats, possums, stoats and other invasive predators by 2050. Is it a pipe dream?
View on Nature
Kinesin inhibitor marches toward first-in-class pivotal trial
TLDR
A KSP-targeted drug looks set to enter late-stage clinical testing, with Array BioPharma announcing plans to launch a global phase 3 trial for its KSP inhibitor, ARRY-520, which seems to inhibit the proteins responsible for regulating cell death, making it easier for the drug to kill cancer cells.
View on Nature
Mapping biomedical research in the USA
View on Elsevier
DATA SHARING. Montreal institute going 'open' to accelerate science.
Starting this year, any work done at the renowned Montreal Neurological Institute (MNI) will conform to the principles of the "open-science" movement—all results and data will be made freely…
View on PubMed
Excitement around hydroxychloroquine for treating COVID-19 causes challenges for rheumatology
View on Elsevier
Amyotrophic lateral sclerosis
TLDR
Treatments for ALS are limited, but new drugs are starting to be approved and stem-cell therapy and gene therapy will soon be coming into their own, and technology is devising new ways for doctors to diagnose cases, monitor progression and get patients into clinical trials.
View on Nature
...
...
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License